These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, Alexander Project Group. J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398 [Abstract] [Full Text] [Related]
3. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Yang Q, Xu Y, Chen M, Wang H, Sun H, Hu Y, Zhang R, Duan Q, Zhuo C, Cao B, Liu Y, Yu Y, Sun Z, Chu Y. Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692 [Abstract] [Full Text] [Related]
4. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN, SENTRY Study Group (Latin America). Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556 [Abstract] [Full Text] [Related]
5. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007]. Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX. Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2983-7. PubMed ID: 20137709 [Abstract] [Full Text] [Related]
7. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. J Antimicrob Chemother; 2009 Mar 17; 63(3):511-9. PubMed ID: 19174454 [Abstract] [Full Text] [Related]
14. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. Jones RN, Fritsche TR, Sader HS, Stilwell MG. Diagn Microbiol Infect Dis; 2007 May 17; 58(1):9-17. PubMed ID: 17408903 [Abstract] [Full Text] [Related]
15. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey. Gonullu N, Catal F, Kucukbasmaci O, Ozdemir S, Torun MM, Berkiten R. Chemotherapy; 2009 May 17; 55(3):161-7. PubMed ID: 19390189 [Abstract] [Full Text] [Related]
16. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. Brown SD, Rybak MJ. J Antimicrob Chemother; 2004 Aug 17; 54 Suppl 1():i7-15. PubMed ID: 15265831 [Abstract] [Full Text] [Related]
18. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Inoue M, Kohno S, Kaku M, Yamaguchi K, Igari J, Yamanaka K. Int J Infect Dis; 2005 Jan 17; 9(1):27-36. PubMed ID: 15603993 [Abstract] [Full Text] [Related]